KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Debt Ratio: 2009-2025

Historic Debt Ratio for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to 0.42.

  • Teva Pharmaceutical Industries' Debt Ratio fell 7.32% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.72, marking a year-over-year decrease of 6.98%. This contributed to the annual value of 0.45 for FY2024, which is 0.87% down from last year.
  • As of Q3 2025, Teva Pharmaceutical Industries' Debt Ratio stood at 0.42, which was down 1.86% from 0.43 recorded in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Debt Ratio registered a high of 0.51 during Q2 2021, and its lowest value of 0.42 during Q3 2025.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Debt Ratio value was 0.45 (recorded in 2024), while the average stood at 0.45.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Debt Ratio climbed by 8.07% in 2021, and later dropped by 7.32% in 2025.
  • Teva Pharmaceutical Industries' Debt Ratio (Quarterly) stood at 0.48 in 2021, then fell by 0.30% to 0.48 in 2022, then decreased by 5.36% to 0.46 in 2023, then dropped by 0.87% to 0.45 in 2024, then declined by 7.32% to 0.42 in 2025.
  • Its Debt Ratio stands at 0.42 for Q3 2025, versus 0.43 for Q2 2025 and 0.43 for Q1 2025.